November 24, 2016 - By Marguerite Chambers
Shore Capital reiterated their “Buy” rating on Exova Group Plc (LON:EXO)‘s stock in analysts note shared with investors on Thursday morning.
Out of 6 analysts covering Exova Group Plc (LON:EXO), 6 rate it a “Buy”, 0 “Sell”, while 0 “Hold”. This means 100% are positive. GBX 225 is the highest target while GBX 158 is the lowest. The GBX 208 average target is 6.12% above today’s (GBX 196) stock price. Exova Group Plc has been the topic of 23 analyst reports since August 24, 2015 according to StockzIntelligence Inc. As per Thursday, September 1, the company rating was maintained by Barclays Capital. The firm has “Buy” rating by Shore Capital given on Friday, January 8. The company was maintained on Thursday, March 3 by Shore Capital. The stock of Exova Group Plc (LON:EXO) has “Hold” rating given on Friday, January 15 by Peel Hunt. The stock of Exova Group Plc (LON:EXO) has “Outperform” rating given on Wednesday, November 11 by Credit Suisse. The company was maintained on Wednesday, August 31 by Peel Hunt. Barclays Capital maintained the shares of EXO in a report on Monday, September 14 with “Overweight” rating. Peel Hunt maintained Exova Group Plc (LON:EXO) rating on Wednesday, November 11. Peel Hunt has “Hold” rating and GBX 165 price target. The firm has “Buy” rating by Shore Capital given on Tuesday, February 23. Peel Hunt maintained the stock with “Add” rating in Wednesday, September 21 report.
About 5,092 shares traded hands. Exova Group Plc (LON:EXO) has risen 20.37% since April 26, 2016 and is uptrending. It has outperformed by 14.96% the S&P500.
Exova Group plc is a United Kingdom well-known provider of testing and advisory services. The company has a market cap of 497.67 million GBP. The Firm is a laboratory testing firm operating approximately 140 laboratories and offices in over 30 countries throughout Europe, the Americas, the Middle East and Asia/Asia Pacific. It has a 24.01 P/E ratio. The Company’s divisions include Europe, Americas and Rest of World.
Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.